BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pezeshki SMS, Saki N, Ghandali MV, Ekrami A, Avarvand AY. Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East. Blood Res 2021;56:38-43. [PMID: 33707351 DOI: 10.5045/br.2021.2020189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Rahmati A, Goshayeshi L, Amini N, Keramati MR, Taraz Jamshidi S, Boroumand-noughabi S. Platelet Count and Indices in Adult Patients Infected with Helicobacter pylori: a Retrospective Study of 1907 Patients. SN Compr Clin Med 2022;4:247. [DOI: 10.1007/s42399-022-01336-5] [Reference Citation Analysis]
2 Takeuchi H, Okamoto A. Helicobacter pylori Infection and Chronic Immune Thrombocytopenia. JCM 2022;11:4822. [DOI: 10.3390/jcm11164822] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Potapova MV, Broyaka NA, Skvortsov KY, Konobeeva EV. Helicobacter pylori roles in haematology disease pathogenesis. Sibirskij nauchnyj medicinskij zhurnal 2022;42:18-35. [DOI: 10.18699/ssmj20220302] [Reference Citation Analysis]
4 Callejas Rubio JL, Ríos Fernandez R, García Martín P. Guidelines of the Spanish ITP Group for the diagnosis, treatment and follow-up of patients with immune thrombocytopenia. Medicina Clínica (English Edition) 2022;158:e1. [DOI: 10.1016/j.medcle.2021.09.022] [Reference Citation Analysis]
5 De Francesco V, Zullo A, Manta R, Pavoni M, Saracino I, Fiorini G, Giostra F, Monti G, Vaira D. First-line therapies for H. pylori infection in Italy: a pooled-data analysis. AGEB 2022;85:295-299. [DOI: 10.51821/85.2.9680] [Reference Citation Analysis]
6 Wang Y, Wu J, Li Y, Yang J, Wang L, Wu A, Huang F, Jiang N, Tang C, Li Y, Tiwari VK. A Rapid and Sensitive UHPLC-MS/MS Method for Determination of 2, 3, 8-Trimethylellagic, a Potent Active Compound from Sanguisorba officinalis L., and Its Application in the Pharmacokinetic Study within Thrombocytopenia Rats. Journal of Chemistry 2021;2021:1-13. [DOI: 10.1155/2021/3309434] [Reference Citation Analysis]
7 Callejas Rubio JL, Ríos Fernandez R, García Martín P. Guidelines of the Spanish ITP Group for the diagnosis, treatment and follow-up of patients with immune thrombocytopenia. Med Clin (Barc) 2021:S0025-7753(21)00627-8. [PMID: 34895892 DOI: 10.1016/j.medcli.2021.09.019] [Reference Citation Analysis]
8 Ihtesham A, Maqbool S, Nadeem M, Bilawal Abbas Janjua M, Sundus O, Bakht Naqqash A, Inayat Mohamed W, Turab Haider S, Ahmad M, Ahmad Talha Mustafa M, Osama Mehboob H. Helicobacter pylori induced Immune Thrombocytopenic Purpura and perspective role of Helicobacter pylori eradication therapy for treating Immune Thrombocytopenic Purpura. AIMS Microbiol 2021;7:284-303. [PMID: 34708173 DOI: 10.3934/microbiol.2021018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Choi PY, Merriman E, Bennett A, Enjeti AK, Tan CW, Goncalves I, Hsu D, Bird R. Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand. Med J Aust 2021. [PMID: 34628650 DOI: 10.5694/mja2.51284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 De Francesco V, Zullo A, Gatta L, Manta R, Pavoni M, Saracino IM, Fiorini G, Vaira D. Rescue Therapies for H. pylori Infection in Italy. Antibiotics (Basel) 2021;10:525. [PMID: 34063624 DOI: 10.3390/antibiotics10050525] [Cited by in F6Publishing: 2] [Reference Citation Analysis]